Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-02

Clinical Trial Update: Influence of the MDR1 Genotype on Blood Levels of Indinavir and Saquinavir in Healthy Volunteers [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update examining how the MDR1 genotype influences blood levels of HIV protease inhibitors indinavir and saquinavir in healthy volunteer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Indinavir (indinavir)
  • Saquinavir (saquinavir)

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Healthy, HIV Infections | Phase 4 | Status: COMPLETED